Search results
Vertex Stock Hit All-Time High, Paused, Rising Again
Investor's Business Daily· 2 days agoTop line growth has also increased over the same time frame...holds the No. 3 rank among its peers in the 740-stock (yes, that's the correct number)...
Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks· 18 hours agoFree Report) reported first-quarter 2024 loss per share of 82 cents, narrower than the Zacks Consensus Estimate of a loss of $1.09. Currently, KOD does not have any approved products in its ...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 1 day agoAnd while success is never certain in the biotech field, CRISPR boasts a $2.1 billion bank account...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoNovo Holdings A/S ("Novo Holdings") today announced that it has agreed to acquire a majority stake in Single Use Support, a fast-growing life science tools company providing ...
KCAS Bio expands global reach into Australia - Kansas City Business Journal
The Business Journals· 10 hours agoTwo years after KCAS Bio broke into the global market, the local life sciences company is further...
Genprex names Jose Moreno Toscano as Board Chairman By Investing.com
Investing.com· 3 days agoGenprex , Inc. (NASDAQ: NASDAQ:GNPX), a clinical-stage gene therapy company, has announced the...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 10 hours agoAvenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and ...
US reclassification could drive fresh research funding into pot sector
Reuters· 3 days agoThe U.S. pot sector could see an influx of medical research funding from healthcare investors amid...
How Gene Editing Therapies Could Go Beyond Rare Diseases
Forbes· 18 hours agoResearch groups around the world believe that gene editing - which seeks to disable the virus...
Angst over looming Chevron decision on health care
Politico· 9 hours agoThe BIOSECURE Act has continued to gain momentum since a Senate committee approved its version in March. WHEN KIDNEYS...Kansas ditching CVS in its new Medicaid contracts. The Wall Street Journal ...
